scholarly journals "Living in Hell": Experiences of Iranian Families Living with Patients with Schizophrenia

Author(s):  
Parviz Molavi ◽  
Saeid Sadeghieh-Ahary ◽  
Mohsen Rezaeian ◽  
Elmira Taghizadeh ◽  
Elhameh Nasiri ◽  
...  

Abstract Background: In addition to bearing on the patients and public, schizophrenia has a tremendous impact on families and caregivers. Its negative consequence has been studied as a burden. In this study, by doing qualitative analysis, we examined the experiences of Iranian families within the Ardabil, Iran, living with patients with schizophrenia. Method: This research was a qualitative study, and data collection was done through an in-depth, unstructured interview. Twenty family members of patients with schizophrenia were interviewed, and data were analyzed by the conventional qualitative content analysis. Results: The major themes of the interviews were classified into 3-level codes. Six subthemes were found in the experiences of patients with schizophrenia families, namely stigma, sense of shame, isolation, need for support, and lack of awareness, and poor quality of life, which were combined and classified into one main category named "living in hell".Conclusions: The findings showed that schizophrenia has an impressive negative effect on the families' welfare; thus, it highlights the necessity to provide interventions to help them adapt to this disorder. The results also highlight that caring is more demanding for families of long-term disease patients.

2004 ◽  
Vol 8 (2_suppl) ◽  
pp. 20-25
Author(s):  
Alan Menter

Patients with psoriasis may experience impaired psychosocial mental status regardless of their objectively defined disease severity. The objective clinical measures of disease that are commonly used to evaluate a patient's psoriasis fail to take into account the effect of psoriasis on patients' quality of life (QOL). As a result, a significant number of patients are dissatisfied with conventional treatments and are searching for new options. A high unmet need for effective and safe long-term therapies that can also improve patients' QOL exists in psoriasis. Alefacept, a selective biologic agent specifically designed for the treatment of psoriasis, provides improvement in both the physical (as measured by the Psoriasis Area and Severity Index) and mental (as measured by the Dermatology Life Quality Index) aspects of the disease. Additionally, alefacept is extremely well tolerated, with no negative effect on QOL, and the improvement in QOL is maintained off-treatment, which is consistent with its remittive effects on the disease. Alefacept helps fulfill the needs of psoriasis patients by providing efficacy, safety, off-treatment remissions, and improvement in QOL.


2018 ◽  
Vol 4 (2) ◽  
pp. 106
Author(s):  
Riza Alfian ◽  
Nani Lisdawati ◽  
Aditya Maulana Perdana Putra ◽  
Ratih Pratiwi Sari ◽  
Fahma Lailani

Hypertension is one of the main factors of coronary heart disease and stroke. The prevalence of hypertension in South Kalimantan Province occupied a second prevalence of 30,8%. Hypertension is a chronic disease that requires long-term treatment. Furthermore, long-term treatment of anti-hypertension patients also have the possibility of side effects that also affect the quality of life of patients. Uncontrolled blood pressure can aggravate the incidence of hypertension and develop into a more dangerous disease that affects the quality of life of patients. The purpose of this study was to determine the description of blood pressure and quality of life of outpatient hypertensive patients at RSUD Ulin Banjarmasin. This research was conducted by using survey method. Sampling was done by consecutive sampling method. Samples meeting the inclusion criteria were 61 patients. The sample inclusion criteria were outpatients ages 18-65 with hypertension diagnoses, and were willing to follow the study. Exclusion criteria were patients with uncooperative, illiterate and deaf conditions. Data collection was done by interviewing and filling out the EQ-5D questionnaire. Blood pressure data were taken from medical records. The data of the research are presented in descriptive form. Based on this research can be concluded that the value of systolic blood pressure and diastolic mean of research sample is 153,82 ± 17,62 and 86,16 ± 10,52 mmHg. The study sample was dominated by patients with level II hypertension (52,5%). Furthermore the quality of life of the average sample was dominated by the category of poor quality of life (73,8%).


2019 ◽  
Vol 28 (18) ◽  
pp. 1180-1186 ◽  
Author(s):  
René Williams ◽  
Philip Hawkins ◽  
Thirusha Lane

Cryopyrin-associated periodic syndrome (CAPS) is a group of rare hereditary autoinflammatory diseases characterised by recurrent flares of mild to severe systemic inflammation and fever. CAPS is the umbrella term for a spectrum of individual conditions, namely familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and neonatal-onset multisystem inflammatory disease (NOMID), also known as chronic infantile neurologic, cutaneous and articular (CINCA) syndrome. The flare symptoms include fever, fatigue, rashes, headaches, arthralgia and myalgia that can last for a few hours or for several days. These symptoms are debilitating, contributing to poor quality of life for patients if left untreated. Serious life-changing complications such as hearing loss, blindness and AA amyloidosis resulting in kidney failure can occur. Until recently, treatment of the disease was symptomatic using non-steroidal anti-inflammatory and immunosuppressant drugs with limited success. In contrast, biological treatments targeting interleukin 1 (IL-1) have proved remarkably effective, often associated with complete and sustained disease remission, vastly improved quality of life and avoidance of serious long-term complications.


F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 791
Author(s):  
Fabienne Langlois ◽  
Gabriela M. Suarez ◽  
Maria Fleseriu

Acromegaly is a complex disease with excessive growth hormone and insulin-like growth factor 1 (IGF-1) causing multisystem effects, particularly cardiovascular, respiratory, and metabolic. Psychological concerns and poor quality of life (QoL) are also major disease consequences. This review is intended for clinicians and focuses on the latest developments related to respiratory and QoL effects of long-term growth hormone excess. Along with biochemical disease control, patient treatment satisfaction and outcomes have become major treatment objectives; current knowledge and tools to evaluate and manage this aspect of the disease are described. Sleep apnea syndrome and other derangements of lung function and apparatus, from pathophysiology to treatment, and evaluation tools and determinants of QoL in patients with acromegaly are discussed.


2019 ◽  
Author(s):  
Luciana Martel ◽  
Helena Bascunana ◽  
Jordi Cuartero ◽  
Betina Biagetti ◽  
Susan M. Webb ◽  
...  

2021 ◽  
Vol 26 (5) ◽  
pp. 236-243
Author(s):  
Alison Norman ◽  
Sue Jackson ◽  
Hannah Ferrario ◽  
Nena Percuklievska ◽  
Pat McBride

Management of pituitary conditions can be problematic with many patients experiencing long-term psychological and social difficulties that impact on their quality of life. This study aimed to identify psychosocial symptoms associated with pituitary conditions that lead to poor quality of life and identify differences in symptomatology between patient groups. A survey using measures of psychological and social symptoms was sent to 2000 members of the Pituitary Foundation in January 2016. The survey was completed by 1062 patients (683 female), aged under 18 to over 65 years, using categorical age ranges. Physical and psychosocial symptoms including appearance issues, fatigue, anxiety and depression were reported. Using correlational and regression analyses, significant variation in symptoms were identified across gender, age range and condition type that were impairing patients' long-term functioning and impacting quality of life. There is a need for greater patient information and advice surrounding psychosocial symptoms of pituitary conditions.


Author(s):  
Gina Rohekar MD FRCPC MSc

Inflammatory arthritis, such as rheumatoid arthritis (RA), is not simply a disease that affects an individual with symptoms in the present. It also has tremendous impact on the patient’s future well-being. RA has been proposed to be an interrelated triad of disease activity, joint damage, and disability.1 In this triad, current disease activity (pain, swelling, and stiffness of joints) leads to disability and decreased quality of life. Furthermore, disease activity leads to joint damage, which also leads to disability.1 In the modern treatment of inflammatory arthritis, the goal is to not only treat the present symptoms (disease activity) but also, by doing so, to decrease damage and disability and improve quality of life. There is a movement to treat inflammatory arthritis aggressively and early, with the thought that there is a “window of opportunity” in which early intervention can prevent long-term consequences.


Author(s):  
Nina Simmons-Mackie

Abstract Purpose: This article addresses several intervention approaches that aim to improve life for individuals with severe aphasia. Because severe aphasia significantly compromises language, often for the long term, recommended approaches focus on additional domains that affect quality of life. Treatments are discussed that involve increasing participation in personally relevant life situations, enhancing environmental support for communication and participation, and improving communicative confidence. Methods: Interventions that have been suggested in the aphasia literature as particularly appropriate for people with severe aphasia include training in total communication, training of communication partners, and activity specific training. Conclusion: Several intervention approaches can be implemented to enhance life with severe aphasia.


Sign in / Sign up

Export Citation Format

Share Document